Gujja V, Sadineni K, Koppula S, Basireddy A, Venkanna B, Gunda S
Curr Drug Discov Technol. 2024; 22(1):e090424228867.
PMID: 38616757
DOI: 10.2174/0115701638282655240402042126.
Chaudhary T, Upadhyay P, Kataria R
Curr Org Synth. 2023; 21(8):1014-1020.
PMID: 38037905
DOI: 10.2174/0115701794265887231014061317.
Okmanov R, Ziyaev A, Abdukarimov A, Toshmurodov T, Kholikov T
Acta Crystallogr E Crystallogr Commun. 2023; 79(Pt 6):552-556.
PMID: 37288462
PMC: 10242748.
DOI: 10.1107/S2056989023004164.
Khan B, Hamdani S, Jalil S, Ejaz S, Iqbal J, Shawky A
Pharmaceuticals (Basel). 2023; 16(1).
PMID: 36678507
PMC: 9865589.
DOI: 10.3390/ph16010011.
Sciarretta M, Barawi M, Navio C, Shea V, Blanco M, Aleman J
ACS Appl Mater Interfaces. 2022; 14(30):34975-34984.
PMID: 35877938
PMC: 9827454.
DOI: 10.1021/acsami.2c07880.
1,3,4, Oxadiazole Compound A3 Provides Robust Protection Against PTZ-Induced Neuroinflammation and Oxidative Stress by Regulating -Pathway.
Alvi A, Shah F, Muhammad A, Feng J, Li S
J Inflamm Res. 2022; 14:7393-7409.
PMID: 35002275
PMC: 8721032.
DOI: 10.2147/JIR.S333451.
Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives.
Glomb T, Swiatek P
Int J Mol Sci. 2021; 22(13).
PMID: 34209520
PMC: 8268636.
DOI: 10.3390/ijms22136979.
Post-Treatment of Synthetic Polyphenolic 1,3,4 Oxadiazole Compound A3, Attenuated Ischemic Stroke-Induced Neuroinflammation and Neurodegeneration.
Alvi A, Al Kury L, Ijaz M, Shah F, Khan M, Sheikh A
Biomolecules. 2020; 10(6).
PMID: 32466476
PMC: 7355474.
DOI: 10.3390/biom10060816.
Evaluating novel synthetic compounds active against Bacillus subtilis and Bacillus cereus spores using Live imaging with SporeTrackerX.
Omardien S, Ter Beek A, Vischer N, Montijn R, Schuren F, Brul S
Sci Rep. 2018; 8(1):9128.
PMID: 29904100
PMC: 6002552.
DOI: 10.1038/s41598-018-27529-4.
Antimicrobial activity of 1,3,4-oxadiazole derivatives against planktonic cells and biofilm of Staphylococcus aureus.
Zheng Z, Liu Q, Kim W, Tharmalingam N, Fuchs B, Mylonakis E
Future Med Chem. 2018; 10(3):283-296.
PMID: 29334249
PMC: 6021908.
DOI: 10.4155/fmc-2017-0159.
Crystal structure and Hirshfeld surface analysis of 1-(4-chloro-phen-yl)-2-{[5-(4-chloro-phen-yl)-1,3,4-oxa-diazol-2-yl]sulfan-yl}ethanone.
Kumar R, Hussain S, Khan K, Perveen S, Yousuf S
Acta Crystallogr E Crystallogr Commun. 2017; 73(Pt 4):524-527.
PMID: 28435712
PMC: 5382613.
DOI: 10.1107/S2056989017003978.
Rapid, Microwave Accelerated Synthesis of [1,2,4]Triazolo[3,4-][1,3,4]oxadiazoles from 4-Acylamino-1,2,4-Triazoles.
Breunig S, Olson M, Harki D
Tetrahedron Lett. 2017; 57(36):4056-4060.
PMID: 28138199
PMC: 5271595.
DOI: 10.1016/j.tetlet.2016.07.082.
Synthesis of a series of novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as potential antioxidant and antibacterial agents.
Aruna Sindhe M, Bodke Y, Kenchappa R, Telkar S, Chandrashekar A
J Chem Biol. 2016; 9(3):79-90.
PMID: 27493696
PMC: 4958064.
DOI: 10.1007/s12154-016-0153-9.
Synthesis, characterization and anti-inflammatory activity of some 1, 3,4 -oxadiazole derivatives.
Singh A, Lohani M, Parthsarthy R
Iran J Pharm Res. 2013; 12(2):319-23.
PMID: 24250606
PMC: 3813233.
Synthesis and bioassay of a new class of furanyl-1,3,4-oxadiazole derivatives.
El Sadek M, Hassan S, Abdelwahab H, Yacout G
Molecules. 2013; 18(7):8550-62.
PMID: 23877049
PMC: 6270226.
DOI: 10.3390/molecules18078550.
Synthetic approaches and pharmacological activity of 1,3,4-oxadiazoles: a review of the literature from 2000-2012.
de Oliveira C, Lira B, Barbosa-Filho J, Lorenzo J, de Athayde-Filho P
Molecules. 2012; 17(9):10192-231.
PMID: 22926303
PMC: 6268307.
DOI: 10.3390/molecules170910192.
8-(2-Chloro-phen-yl)-1-(4-chloro-phen-yl)-4-[(E)-(2-chloro-phen-yl)methyl-idene]-6-methyl-4,5,6,7,7a,8-hexa-hydro-1,2,4-oxadiazolo[5,4-d]pyrido[3,4-c][1,5]benzothia-zepine.
Rajni Swamy V, Periathai R, Rajagopal K, Krishnakumar R, Srinivasan N
Acta Crystallogr Sect E Struct Rep Online. 2011; 66(Pt 5):o1119.
PMID: 21579170
PMC: 2979104.
DOI: 10.1107/S1600536810013309.
Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by a new series of substituted-1,3,4-oxadiazole derivatives.
Kumar A, DSouza S, Gaonkar S, Rai K, Salimath B
Invest New Drugs. 2008; 26(5):425-35.
PMID: 18227972
DOI: 10.1007/s10637-008-9116-5.